NCT07313202 2025-12-31
Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance
Fujian Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT02078700 2025-06-25
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
NCT04832204 2021-04-05
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Beijing Hospital
Phase 2 Unknown
NCT02950103 2019-09-30
Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients
Secretaria de Estado da Saúde
Phase 2 Terminated
NCT00886028 2009-04-22
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma
National Institute of Cancerología
Phase 2 Unknown
NCT00404508 2006-11-28
A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors
National Institute of Cancerología
Phase 2 Completed